MIA Antikörper (AA 87-124)
-
- Target Alle MIA Antikörper anzeigen
- MIA (Melanoma Inhibitory Activity (MIA))
-
Bindungsspezifität
- AA 87-124
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MIA Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Melanoma-derived growth regulatory protein (87-124AA)
- Isotyp
- IgG
- Top Product
- Discover our top product MIA Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- MIA (Melanoma Inhibitory Activity (MIA))
- Andere Bezeichnung
- MIA (MIA Produkte)
- Synonyme
- CD-RAP antikoerper, Mia1 antikoerper, Cdrap antikoerper, zgc:194157 antikoerper, mia antikoerper, CDRAP antikoerper, Fdp antikoerper, MIA antikoerper, MIAL antikoerper, melanoma inhibitory activity antikoerper, otoraplin antikoerper, cilia and flagella associated protein 100 antikoerper, MIA antikoerper, Mia antikoerper, mia antikoerper, Otor antikoerper, CFAP100 antikoerper
- Hintergrund
-
Background: Elicits growth inhibition on melanoma cells in vitro as well as some other neuroectodermal tumors, including gliomas.
Aliases: Cartilage derived retinoic acid sensitive protein antibody, CD RAP antibody, CDRAP antibody, Melanoma derived growth regulatory protein precursor antibody, Melanoma inhibitory activity protein antibody, Melanoma-derived growth regulatory protein antibody, Mia antibody, MIA_HUMAN antibody
- UniProt
- Q16674
-